Jessica Walker is joining Atlanpole Biotherapies as European Project Manager
Jessica Walker is joining Atlanpole Biotherapies as European Project Manager. She will be working primarily on 3 European projects: CE4BIG,... View Article
HealthTech Innovation Days Announce Details of Conference Program & Attendees
With strong support from the healthtech ecosystem shown by sponsors renewing their participation from last edition and additional newcomers eager... View Article
New member | SELHA GROUP
SELHA GROUP is an industrial group expert in electronics. Located in France & Morocco, SELHA GROUP is specialized in design,... View Article
Valneva Announces New IXIARO® Supply Contract with the US Government worth up to $166 million
Saint Herblain (France), September 9, 2020 – Valneva SE (“Valneva”), a specialty vaccine company, today announced the signing of a new contract, lasting... View Article
OSE Immunotherapeutics Publishes Positive Preclinical COVID-19 Vaccine Results With Multi-Target Vaccine CoVepiT
Data support potential as novel and differentiated COVID-19 vaccine designed against multiple SARS-CoV-2 targets with technology known to induce memory... View Article
New member | L’Oeil Electrique
L’OEIL ELECTRIQUE is an audiovisual production agency that produces video content for business communication. LOE SANTÉ is part of LOEIL... View Article
New member | Hoppen
HOPPEN develops technological tools and solutions intended to support hospitals and clinics in their digital transformation, providing concrete responses to... View Article
Owkin Closes Series A Round to Deploy Federated Learning for Research at Scale, with a Total of $70M Raised
Series A round closed with an $18 million commitment from Mubadala Investment Company’s asset management arm, Mubadala Capital in... View Article
The CE4BIG project: A European project federating four major clusters in the healthcare sector
The French Atlanpole Biotherapies in Nantes is federating four major healthcare clusters aimed at fostering business growth in SMEs specialising... View Article
XENOTHERA secures funding of its anti-Covid treatment, and accelerates its product portfolio by a total amount of more than 7 million euros
XENOTHERA, a Nantes-based biotech created in 2014, today announced that it has been awarded 2.3 million euros by the French Government,... View Article